drugset / Trial / NCT05261360

Clinical Efficacy of Exosome in Degenerative Meniscal Injury

NCT05261360 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Comparison of intra-articular administration of synovial fluid-derived mesenchymal stem cells-derived exosomes with synovial fluid-derived mesenchymal stem cells on the same patient.

Timeline

Start
2022-03
Primary completion
2024-03
Completion
2025-03

Drugs

EvaluationDrugModalityDoseRoute
Subject SF-MSC Cell therapy 1 cells/kg Other
Subject SF-MSC-EX Other / unclassified 1 cells/kg Other

Indications